Results 41 to 50 of about 2,835 (171)

Therapeutic use of psilocybin: Practical considerations for dosing and administration

Frontiers in Psychiatry, 2022
The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals.
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, Jagpaul Kaur Deol   +3 more
doaj   +1 more source

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

European Psychiatry, 2023
Introduction During the last decade there has been a resurgence of interest on the use of psychedelics as novel treatments for mental disorders, including treatment-resistant depression (TRD). Psilocybin, the chemical component of “magic mushrooms”, has
M. I. Husain, D. M. Blumberger, D. J. Castle, S. M. Kloiber, A. Ortiz, J. D. Rosenblat, B. H. Mulsant   +6 more
doaj   +1 more source

Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy

Methodological issues undermine evidence about adverse effects of psilocybin-assisted ...
Jonathon Marinis, Sarah Tomoyo Clarke, Gillinder Bedi   +2 more
openaire   +2 more sources

Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective

Frontiers in Psychiatry, 2023
The efficacy of psilocybin and other psychedelics as modes of treatment have been demonstrated through clinical trials and other studies in the management of a number of mental illnesses, including some treatment resistant cases.
Winston De La Haye, Geoffrey Walcott, Jordan Eaton, Jhoelle Beckford, Janelle Greene   +4 more
doaj   +1 more source

Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience [PDF]

, 2021
Attachment insecurity is determined early in life, is a risk factor for psychopathology, and can be measured on two separate continuous dimensions: attachment anxiety and attachment avoidance.
Stauffer, Christopher S, Ortigo, Kile M, Woolley, Joshua, Anderson, Brian T   +3 more
core   +1 more source

Therapeutic effect of psilocybin in addiction: A systematic review

Frontiers in Psychiatry, 2023
BackgroundPsychedelic-assisted therapy [e.g., with lysergic acid diethylamide (LSD)] has shown promising results as treatment for substance use disorders (SUDs).
Pim B. van der Meer, Pim B. van der Meer, Juan J. Fuentes, Juan J. Fuentes, Juan J. Fuentes, Ad A. Kaptein, Jan W. Schoones, Marleen M. de Waal, Marleen M. de Waal, Marleen M. de Waal, Anneke E. Goudriaan, Anneke E. Goudriaan, Anneke E. Goudriaan, Kees Kramers, Arnt Schellekens, Arnt Schellekens, Metten Somers, Matthijs G. Bossong, Albert Batalla   +18 more
doaj   +1 more source

Will psilocybin lose its magic in the clinical setting?

Therapeutic Advances in Psychopharmacology, 2022
Psilocybin as a novel treatment for depression is garnering a lot of attention from both the mainstream media and the academic community. Although phase 3 trials are only just beginning, we feel that it is important for clinicians to consider what ...
Caroline Hayes, Mourad Wahba, Stuart Watson   +2 more
doaj   +1 more source

The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions

Frontiers in Pharmacology, 2018
Research on the clinical applications of psychedelic-assisted psychotherapy has demonstrated promising early results for treatment of alcohol dependence.
Elizabeth M. Nielson, Darrick G. May, Alyssa A. Forcehimes, Michael P. Bogenschutz   +3 more
doaj   +1 more source

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?

Pharmaceuticals, 2022
Psilocybin has been suggested as a promising transdiagnostic treatment strategy for a wide range of psychiatric disorders. Recent findings showed that psychedelic-assisted/”psycholitic” psychotherapy should provide significant and sustained alleviation ...
Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella   +5 more
doaj   +1 more source

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer. [PDF]

Nat Ment Health
Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S.   +7 more
europepmc   +2 more sources